Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis
Introduction
Comorbidities are common at any severity degree of chronic obstructive pulmonary disease (COPD) [1], [2]. Cardiovascular disease (CVD) is a major comorbidity in COPD patients [1], [2]. Particularly, ischemic heart disease (IHD) and COPD are among the principal causes of mortality and morbidity in western countries and are frequently associated [1], [2]. IHD as well as heart failure or pulmonary embolism (PE) are reported as the main causes of death for patients affected by COPD [2], [3]. The natural history of at least one third of COPD patients is characterized by recurrent episodes of acute exacerbation (AECOPD) [2]. These episodes of AECOPD increase the risk of mortality (cardiac and all-cause) and of myocardial infarction (MI) [2], [3], [4], [5]. Several authors attempted to understand whether elevation of cardiac troponin (Tn) during AECOPD, in the absence of signs and symptoms suggestive of concomitant MI, could discriminate patients at higher mortality risk [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]. The results are conflicting and the prognostic role of Tn elevation in AECOPD is still uncertain. Differences in inclusion/exclusion criteria, sample size, type of Tn, follow-up and endpoint's definition between various studies may contribute to explain these discrepancies [6], [7], [8], [9], [10], [11], [12], [13], [14], [15]. Consequently, Tn measurements are not systematically used to manage AECOPD patients in daily clinical practice. Systematic reviews employing meta-analytic techniques provide quantitative and objective means to pool and assess available clinical evidence, emphasizing internal validity and homogeneity. Therefore, we performed a comprehensive systematic review and meta-analysis of available studies to assess the value of cardiac Tn elevation to predict all-cause mortality in patients admitted to the hospital for AECOPD.
Section snippets
Methods
We performed a systematic review and meta-analysis following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) amendment to the Quality of Reporting of Meta-analyses (QUOROM) statement and the recommendations from The Cochrane Collaboration and Meta-analysis of Observational Studies in Epidemiology (MOOSE) [16], [17], [18], [19].
Search results and study selection
After removal of duplicates, 302 studies were analyzed with database search. 276 studies were excluded after the first evaluation of the title and abstract, as they did not meet pre-specified inclusion and exclusion criteria. Twenty-five reports were screened and analyzed. Fifteen studies were excluded from analysis: two were just abstracts, one was a comment on previous data, three included only patients with a stable phase of COPD, one failed to provide complete data on troponin, one was a
Discussion
The main finding of our meta-analysis is that cardiac Tn elevation in patients admitted to the hospital for AECOPD is associated with an increased risk for all-cause mortality. These findings are not influenced by the length of follow-up. There is just a slight discrepancy between Tn T and Tn I assays. Cardiac Tn I elevation failed to predict all-cause mortality, but this could be due to the limited number of studies (n = 3) and to degree of heterogeneity (I2 = 73%).
Cardiac Tn elevation during
Conclusions
Our meta-analysis shows that cardiac Tn elevation at the time of hospital admission for acute exacerbation of COPD is associated with an increased risk of all-cause mortality.
The following is the supplementary data related to this article.
Conflict of interest
The authors report no relationships that could be construed as a conflict of interest.
Acknowledgment
This work was supported by the year 2014 grant from Fondazione Anna Maria Sechi per il Cuore (FASC), Italy. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.
References (32)
- et al.
A postmortem analysis of major causes of early death in patients hospitalized with COPD exacerbation
Chest
(2009) - et al.
Increased risk of myocardial infarction and stroke following exacerbation of COPD
Chest
(2010) - et al.
Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention
Chest
(2013) - et al.
Cardiac biomarkers predict outcome after hospitalisation for an acute exacerbation of chronic obstructive pulmonary disease
Int. J. Cardiol.
(2012) - et al.
Improving the quality of reports of meta-analyses of randomized controlled trials: the QUOROM statement
Lancet
(1999) - et al.
Meta-analysis in clinical trials
Control. Clin. Trials
(1986) - et al.
Troponin elevation during exacerbations of chronic obstructive airways disease due to stress cardiomyopathy
Int. J. Cardiol.
(2012) 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur. Heart J.
(Oct 1 2014)Global initiative for chronic obstructive lung disease—global strategy for the diagnosis, management and prevention for chronic obstructive pulmonary disease
(2014)- et al.
Cardiac troponin I in patients with severe exacerbation of chronic obstructive pulmonary disease
Intensive Care Med.
(2003)
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation
Eur. Respir. J.
Cardiac troponin-I predicts long-term mortality in chronic obstructive pulmonary disease
COPD
Prognostic value of cardiac troponin I in patients with COPD acute exacerbation
Neth. J. Med.
Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD
Thorax
Elevated high sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease
Thorax
Is elevated troponin associated with in-hospital mortality in emergency department patients admitted with chronic obstructive pulmonary disease?
Eur. J. Emerg. Med.
Cited by (66)
The impact of cardiac troponin in elderly patients in the absence of acute coronary syndrome: A systematic review
2020, IJC Heart and VasculatureCitation Excerpt :Table 1 refers to the characteristic of included study. The prognostic role of cTn was explored individually for COPD [10], acute stroke [11], critically care patients [21,24], HTN [5] and for RF, PAD, arrhythmia, HF and DM as well [28]. Therefore, the prognostic implications of elevated cTn seem to be correlated with all-cause mortality in geriatric patients without ACS.
Wireless continuous single-lead ST-segment monitoring to detect new-onset myocardial injury at the general ward—An exploratory subanalysis
2024, Acta Anaesthesiologica Scandinavica